Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 66084.97 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated sales of Rs 5154.17 Crore, up 3.65 % from last quarter Sales of Rs 4972.58 Crore and up 21.72 % from last year same quarter Sales of Rs 4234.55 Crore. Company reported net profit after tax of Rs 752.51 Crore in latest quarter.
Investment Rationale
The brokerage continues to value CIPLA at 22x 12 months forward earnings to arrive at TP of INR900. It maintains neutral on limited upside from current levels.
Promoter/FII Holdings
Promoters held 36.6 per cent stake in the company as of Dec 30, 2020, while FIIs held 22.2 per cent, DIIs 17.9 per cent and public and others 23.2 per cent.
